Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RIGL
#2824
Rigel Pharmaceuticals Inc. (New)
31.390
0
USD
+4.74%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+4.74%
Mudança mensal
+18.36%
Mudança em 6 meses
+4.18%
Mudança anual
+4.18%
Fechamento anterior
29.970
0
Abrir
31.390
0
Bid
Ask
Mínimo
31.390
0
High
31.390
0
Volume
53
Mercados
Ações
Cuidados de saúde
RIGL
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
17 M
17.17 M
17.37 M
17.54 M
17.86 M
18.47 M
—
Valuation ratios
Enterprise value
604.07 M
456.83 M
249.21 M
283.55 M
303.99 M
803.52 M
2.01 B
Price to earnings ratio
—
-24.09
-3.94
-10.43
16.99
2.2
18.83
Price to sales ratio
—
3.03
1.92
2.17
1.66
2.74
7.41
Price to cash flow ratio
—
76.86
-3.13
-44.24
9.45
10.67
32.32
Price to book ratio
—
14.87
-16.97
-8.87
90.48
2.06
-5.29
Enterprise value to EBITDA ratio
-19.98
-30.85
-3.72
-10.74
9.99
5.98
19.18
Profitability ratios
Return on assets %
-0.27
-0.11
-0.44
-0.21
0.11
0.71
0.99
Return on equity %
-0.87
-0.59
4.3
0.88
5.32
0.94
2.27
Return on invested capital %
-167.5
-90.01
-299.96
-164.29
155.66
736.83
959.1
Gross margin %
99.18
99.27
98.55
93.92
89.6
93.33
371.93
Operating margin %
-26.67
-8.37
-46.2
-17.53
13.49
42.63
158.15
EBITDA margin %
-26.02
-9.47
-46.6
-17.78
13.61
42.64
170.9
Net margin %
-27.38
-12
-48.71
-21.47
9.75
124.72
504.29
Liquidity ratios
Quick ratio
2.14
2.33
1.64
1.76
2.04
2.3
8.47
Current ratio
2.18
2.43
1.78
1.86
2.13
2.42
8.92
Inventory turnover
0.6
0.26
0.22
0.97
3.24
2.24
2.31
Asset turnover
0.84
1.07
0.8
0.93
1.28
0.87
1.34
Solvency ratios
Debt to assets ratio
0.36
0.12
0.31
0.51
0.37
0.1
0.99
Debt to equity ratio
1.15
0.68
-3.01
-2.1
18.33
0.14
4.67
Long term debt to total assets ratio
0.18
0.12
0.3
0.51
0.37
0.1
0.98
Long term debt to total equity ratio
0.59
0.66
-2.94
-2.09
18.25
0.13
4.61
Per share metrics
Operating cash flow per share
—
0.34
-4.28
-0.33
1.78
4.02
4.05
EBIT per share
—
-0.73
-3.22
-1.18
1.37
6.66
6.78
EBITDA per share
—
-0.83
-3.25
-1.19
1.38
6.66
7.25
Total debt per share
—
1.22
2.38
3.46
3.41
2.81
12.66
Cash per share
—
7.33
3.38
3.27
4.37
8.23
25.61
Net current asset value per share
—
9.06
6.72
5.7
7.64
12.75
41.69
Tangible book value per share
—
1.78
-1.66
-2.44
-1.35
19.47
26.93
Working capital per share
—
5.33
2.94
2.64
4.06
7.48
23.06
Book value per share
—
1.78
-0.79
-1.65
0.19
20.78
32.45
Notícias
Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?
Micron and Coinbase among market cap stock movers on Wednesday
Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript
Rigel apresenta crescimento anual de 60% e dados promissores em SMD
Rigel Q4 2025 slides: 60% annual growth, promising MDS data
Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates
X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval
Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan
Implied Volatility Surging for Rigel Pharmaceuticals Stock Options
Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline
Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates